CRISTINA TRUMAN: Open Payments
NPI 1568576684 · WACO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$19,777 in 63 payments from 11 companies in 2025. Trend: 2023 $26,645 · 2024 $22,888 · 2025 $19,777
Speaker / faculty: $10,565Travel & lodging: $5,357Food & beverage: $1,911Honoraria: $1,875Education: $69
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 30 | $13,000 |
| MAYNE PHARMA COMMERCIAL LLC | 15 | $6,250 |
| Sumitomo Pharma America, Inc. | 4 | $243 |
| ABBVIE INC. | 2 | $55 |
| Astellas Pharma Global Development | 2 | $52 |
| Organon LLC | 3 | $45 |
| Biogen, Inc. | 2 | $41 |
| Evofem Biosciences, Inc. | 2 | $34 |
| Medtronic, Inc. | 1 | $20 |
| PFIZER INC. | 1 | $20 |
Products named: Veozah, ANNOVERA, GEMTESA, MYFEMBREE, NEXPLANON, ZURZUVAE, Phexxi, QULIPTA.
Industry payments across TX — which companies pay providers there.
